Sign inJoin waitlistJoin the waitlist

MJ

Murali Janakiram

Associate Professor, Department of Hematology & Hematopoietic Cell Transplantation · City of Hope National Medical Center

Credentials: · · · · · · ·

History

City of Hope National Medical Center
Present

Hematology
2007–2008
Internal Medicine
2004–2007
Doctor of Medicine
2000–2004

Research

Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study
The Lancet Oncology · 2021 · 515 citations
The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3
Review · Immunological Reviews · 2017 · First of 6 authors · 209 citations
New immunotherapies targeting the PD-1 pathway
Review · Trends in Pharmacological Sciences · 2015 · 146 citations

Amit Verma
30 papers
Aditi Shastri
22 papers
Ioannis Mantzaris
22 papers
IB
Ira Braunschweig
21 papers
Noah Kornblum
20 papers
OD
Olga Derman
18 papers
Urvi Shah
13 papers · 9 as a fellow
Alejandro Sica
12 papers
Nishi Shah
12 papers · 6 as a fellow
Yanhua Wang
12 papers
DH
Doris Hansen
10 papers
Gurbakhash Kaur
10 papers · 1 as a fellow

Clinical trials

Mezigdomide (CC-92480) Post Idecabtagene Vicleucel in Treating Patients With Relapsed Multiple Myeloma
Principal investigator · Recruiting · Phase 1
City of Hope Medical Center
2024–2026
Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AML
Principal investigator · Completed · Phase 1
Masonic Cancer Center, University of Minnesota
2017–2020
Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant
Principal investigator · Terminated
Albert Einstein College of Medicine
2013–2015